Different Loop Gain Phenotypes in Patients With Chronic Systolic Heart Failure and Periodic Breathing
NCT03532412 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 12
Last updated 2023-12-15
Summary
Central sleep apnoea (CSA) is common in patients with chronic systolic heart failure (HFrEF). Various trials have shown a prevalence of 21 - 37% in this group of people. Up to 66% of patients with CSA and HFrEF present with periodic breathing (PB), which is considered being a marker of HF severity and poor prognosis. Brack et al. summarized data from cohorts, longitudinal studies and retrospective analyses showing an independently increased risk of death in HF patients with PB (HR 2.1-5.7 in five of seven studies). Furthermore, PB in HF patients is known to reduce quality of life and exercise performance and to increase sympathetic nerve activity as well as the probability of malignant cardiac arrhythmias.
The pathogenesis of PB is characterized by an instability of ventilatory drive. The level of carbon dioxide (CO2) in blood and cerebrospinal fluid correlates linearly with minute ventilation. A high level of CO2 increases ventilation while hypocapnia dampens it. This control theory is based on the loop gain (LG), which represents the sensitivity and reactivity of the ventilatory system and comprises three components: The plant gain defines the capacity of the system to change PaCO2 in response to a change in ventilation (metabolic response). It is influenced by the lung volume as well as the anatomy of the thorax and the upper airways. The feedback gain is defined by the chemoreceptor responsiveness in reaction to blood gas changes. The controller gain is represented by the respiratory control center in the brain stem and defines the capacity of the system to change ventilation in response to a change in PaCO2 (ventilatory response).
Sands et al. proposed and validated a mathematical model based on the ventilatory cycle pattern that quantifies the feedback loop. The ratio of ventilatory and cycle duration within the PB pattern is defined as the duty ratio (DR), which is the basis to calculate the LG. Any temporary breathing disturbance causing a PB pattern with a LG \< 1 stabilizes within a few breathing cycles. A LG \> 1 represents an unstable ventilatory response and slight changes of CO2 are accompanied by overshooting and undershooting of the ventilation. In that case, the polysomnography shows the typical pattern of waxing and waning of the tidal volume and effort.
HF patients typically present with an increased LG due to an impaired left ventricular function and a hyperstimulation of pulmonary vagal receptors. Furthermore, Khoo showed an increased chemosensitivity (controller gain) as well as a decreased ventilatory capacity (plant gain) in this group of people.
Sands and colleagues characterized PB considering the mean LG derived from several ventilatory cycles during non-REM sleep. This retrospective study of PB in HFrEF patients addresses the following questions:
1. Is a single LG value appropriate to characterize the individual PB?
2. Does the LG depend on sleep stage and body position?
3. Does the intraindividual LG variability allow for the discrimination of different PB phenotypes and, if so, do these phenotypes differ in further characteristics?
Conditions
- Periodic Breathing
Sponsors & Collaborators
-
Wissenschaftliches Institut Bethanien e.V
lead OTHER
Principal Investigators
-
Winfried J Randerath, Prof. Dr. · Director
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-06-28
- Primary Completion
- 2016-11-14
- Completion
- 2016-11-14
Countries
- Germany
Study Locations
More Related Trials
-
New Biomarkers in Heart- and Renal Failure
NCT02830464 ·Status: COMPLETED
-
Acute Cardiac Dysfunction in Critical Illnes
NCT05860504 ·Status: RECRUITING
-
Tissue Factor Expression in Stage C Heart Failure
NCT00935740 ·Status: COMPLETED
-
Strain X Cardiopulmonary Test
NCT02869178 ·Status: UNKNOWN
-
Evaluation of Respiratory Parameters and Functional Capacity in Coronary Artery Patients
NCT05549739 ·Status: UNKNOWN
-
Assessment of Functional Capacity and Inflammatory Markers in Women With Heart Failure With Preserved Ejection Fraction
NCT02649400 ·Status: UNKNOWN
-
Impact of Heart Failure Center Program on Cardiac Outcomes in Patients With Heart Failure
NCT01416285 ·Status: COMPLETED
-
Assessment of the Link Between Monomeric Functional Form Plasma Level of Vasostatin-1 and Occurrence of New Onset Atrial Fibrillation in Severe Intensive Care Patients
NCT03457155 ·Status: UNKNOWN ·Phase: NA
-
Inflammation, Epigenetics in CHF Patients With AF
NCT07152301 ·Status: COMPLETED
-
Transpulmonary Gradient After Cardiac Surgery Under Cardiopulmonary Bypass
NCT01723930 ·Status: UNKNOWN
-
Change of NLRP3 Inflammasome Expression Level, Symptoms, and Functional Status in HFpEF Patients Treated With ARNI
NCT04269057 ·Status: UNKNOWN
-
Salivary Extracellular Vesicle Associated lncRNAs in Heart Failure (SEAL-HF)
NCT06169540 ·Status: RECRUITING
-
MAP( Mean Arterial Pressure) and Mortality Relation in Patients With Heart Failure
NCT06515366 ·Status: RECRUITING
-
Prospective Analysis Of Cardiac Function In Cirrhotic Patients By Echocardiography And Its Correlation With Events
NCT01433848 ·Status: UNKNOWN
-
Adipose Tissue Inflammation in HFpEF
NCT04886713 ·Status: UNKNOWN
-
Biomaterial Collection - and Analysis in Cardiac Sarcoidosis
NCT05793398 ·Status: NOT_YET_RECRUITING
-
The Current Status and Clinical OUTcomes of Cardiogenic Shock Patients And the Role of Specialist in Cardiovascular Critical Care Unit
NCT05415332 ·Status: RECRUITING
-
Fontan-Sprechstunde
NCT05563376 ·Status: RECRUITING ·Phase: NA
-
Hormone Deficiency in Heart Failure With Preserved Ejection Fraction
NCT02976350 ·Status: COMPLETED
-
Circadian Function and Cardio-metabolic Risk in Adrenal Insufficiency
NCT03000231 ·Status: COMPLETED
-
Persistent Symptoms and Early Incomplete Recovery After Acute Stress-induced Cardiomyopathy: Is There Ongoing Heart Distress? The HEROIC Study
NCT02989454 ·Status: COMPLETED
-
Cardiovascular Metabolic Remodeling in Shock
NCT06285513 ·Status: NOT_YET_RECRUITING
-
Metabolic Remodeling in Fontan Patients
NCT03886935 ·Status: COMPLETED
-
Use of Red Cell Distribution Width for Prediction of New-onset Atrial Fibrillation in Critically Ill Sepsis Patients
NCT03523676 ·Status: COMPLETED
-
The TOSCA Registry: Hormonal and Metabolic Deficiencies in Chronic Heart Failure
NCT02335801 ·Status: UNKNOWN